Effect of a copayment on use of the emergency department in a health maintenance organization

The New England Journal of Medicine
J V SelbyB E Swain

Abstract

Use of the emergency department for nonemergency care is frequent and costly. We studied the effect of a copayment on emergency department use in a group-model health maintenance organization (HMO). We examined the use of the emergency department in 1992 and 1993 by 30,276 subjects who ranged in age from 1 to 63 years at the start of the study and belonged to the Kaiser Permanente HMO in northern California. We assessed their use of various HMO services and their clinical outcomes before and after the introduction of a copayment of $25 to $35 for using the emergency department. This copayment group was compared with two randomly selected control groups not affected by the copayment. One control group, with 60,408 members, was matched for age, sex, and area of residence to the copayment group. The second, with 37,539 members, was matched for these factors and also for the type of employer. After adjustment for age, sex, socioeconomic status, and use of the emergency department in 1992, the decline in the number of visits in 1993 was 14.6 percentage points greater in the copayment group than in either control group (P<0.001 for each comparison). Visits for urgent care did not increase among subjects in any stratum defined by age ...Continue Reading

References

Sep 1, 1991·Annals of Emergency Medicine·D P AndrulisV B Weslowski
May 1, 1989·American Journal of Public Health·N LurieJ P Newhouse
Jul 1, 1988·The Journal of Emergency Medicine·W E DaleyG R Braen
Jul 1, 1985·Annals of Emergency Medicine·D P BueschingR Porter
Aug 22, 1985·The New England Journal of Medicine·K F O'GradyR H Brook
Oct 11, 1985·JAMA : the Journal of the American Medical Association·E B KeelerJ P Newhouse
Dec 8, 1983·The New England Journal of Medicine·R H BrookJ P Newhouse
Dec 17, 1981·The New England Journal of Medicine·J P NewhouseR H Brook
May 1, 1994·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·A BirnbaumW Carter
Apr 27, 1995·The New England Journal of Medicine·J Blustein
Mar 1, 1995·The Journal of Emergency Medicine·M AfilaloJ Lloyd
Mar 1, 1995·Annals of Emergency Medicine·D W BakerR H Brook
Jan 1, 1994·Health Affairs·L C Baker, L S Baker
Jun 22, 1994·JAMA : the Journal of the American Medical Association·A L Kellermann
Mar 1, 1993·American Journal of Public Health·K GrumbachA Bindman

❮ Previous
Next ❯

Citations

Feb 29, 2008·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Daniel Simonet
Mar 13, 2008·Journal of Medical Systems·Daniel A VardyPesach Shvartzman
Jan 5, 2002·Journal of Health Economics·T H WagnerJ H Hibbard
Jan 26, 2008·International Journal of Technology Assessment in Health Care·Akira BabazonoAlan Hillman
Mar 7, 1996·The New England Journal of Medicine·R Steinbrook
Jul 18, 1996·The New England Journal of Medicine·S D Shafran
Jun 12, 1997·The New England Journal of Medicine·J V Selby
Oct 27, 1997·The New England Journal of Medicine·S B Soumerai, D Ross-Degnan
Jan 25, 2008·The New England Journal of Medicine·Amal N TrivediJohn Z Ayanian
Jan 29, 2010·The New England Journal of Medicine·Amal N TrivediVincent Mor
Jan 22, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·L E MarksonB J Turner
Feb 3, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J R Richards, S J Ferrall
Nov 24, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·T LiuS C Carleton
Jul 1, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·R G BuckleyD Slymen
Aug 5, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·H J AlterJ L Zazzali
Nov 3, 2001·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·L D Richardson, U Hwang
Jul 17, 1998·BMJ : British Medical Journal·J Roberts
Jun 16, 2000·The Western Journal of Medicine·J R RichardsR W Derlet
Apr 17, 2007·Journal of Epidemiology and Community Health·Lourdes LostaoPierre Aïach
Nov 4, 2008·Annual Review of Public Health·Dahlia K Remler, Jessica Greene
Nov 26, 2010·The American Economic Review·Amitabh ChandraRobin McKnight
May 21, 2011·The Journal of Economic Perspectives : a Journal of the American Economic Association·Katherine Baicker, Dana Goldman
Apr 2, 2009·Pediatrics·Alison A GalbraithTracy A Lieu
Mar 24, 2000·The Journal of Emergency Medicine·D M LishnerL G Hart
Jul 8, 1999·American Journal of Public Health·K Sullivan
Nov 26, 1999·Journal of General Internal Medicine·A F BrownA E Washington
Oct 1, 1998·Journal of General Internal Medicine·K J RaskD W Baker
Mar 11, 2004·Journal of General Internal Medicine·David W BakerJennifer Peel
Jan 12, 2000·American Journal of Public Health·R A RosenblattL G Hart
Oct 10, 2003·American Journal of Public Health·Ingrid Oakley-GirvanAlice S Whittemore
Feb 21, 2008·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Jin-An HuangJer-San Hu
Jun 12, 2012·Gaceta sanitaria·Agustín Julián-Jiménez
May 17, 2011·The American Journal of Emergency Medicine·Anthony S KimS Claiborne Johnston
Jan 24, 2012·Gaceta sanitaria·Joan BenachCarles Muntaner
Sep 10, 2010·The American Journal of Emergency Medicine·Anthony S KimS Claiborne Johnston
Jun 1, 1996·Pediatric Annals·W A Altemeier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.